Breaking News Instant updates and real-time market news.

FPRX

Five Prime

$53.43

-6.02 (-10.13%)

07:55
12/08/16
12/08
07:55
12/08/16
07:55

Five Prime to host research and development day

Research and Development Day to be held in New York on December 8 at 8 am. Webcast Link

  • 08

    Dec

  • 14

    Dec

FPRX Five Prime
$53.43

-6.02 (-10.13%)

01/21/16
01/21/16
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 3M (MMM) initiated with a Buy at Citi... AMAG Pharmaceuticals (AMAG) initiated with an Equal Weight at Barclays... Acceleron (XLRN) initiated with an Outperform at Credit Suisse... Agios Pharmaceuticals (AGIO) initiated with an Outperform at Credit Suisse... Akebia (AKBA) initiated with a Neutral at Credit Suisse... CIT Group (CIT) initiated with a Hold at Deutsche Bank... Check Point (CHKP) initiated with a Neutral at Cleveland Research... Clovis (CLVS) initiated with an Outperform at Credit Suisse... Colfax (CFX) initiated with a Sell at Citi... Danaher (DHR) initiated with a Neutral at Citi... Dover (DOV) initiated with a Neutral at Citi... Emerson (EMR) initiated with a Sell at Citi... Endo (ENDP) initiated with an Equal Weight at Barclays... Endocyte (ECYT) initiated with an Outperform at Credit Suisse... FibroGen (FGEN) initiated with a Neutral at Credit Suisse... FireEye (FEYE) initiated with an Outperform at Northland... Five Prime (FPRX) initiated with an Outperform at Credit Suisse... Flowserve (FLS) initiated with a Neutral at Citi... General Electric (GE) initiated with a Buy at Citi... Honeywell (HON) initiated with a Buy at Citi... Ignyta (RXDX) initiated with an Outperform at Credit Suisse... Illinois Tool Works (ITW) initiated with a Buy at Citi... Imperva (IMPV) initiated with an Outperform at Northland... Ingersoll-Rand (IR) initiated with a Buy at Citi... Joint Corp. (JYNT) initiated with a Buy at Maxim... M&T Bank (MTB) resumed with a Neutral at JPMorgan... Medivation (MDVN) initiated with an Outperform at Credit Suisse... Newfield Exploration (NFX) initiated with an Outperform at Imperial Capital... OvaScience (OVAS) initiated with an Underperform at Credit Suisse... PFSweb (PFSW) initiated with a Buy at Canaccord... Palo Alto (PANW) initiated with an Outperform at Northland... Perrigo (PRGO) initiated with an Overweight at Barclays... Prothena (PRTA) initiated with an Outperform at Credit Suisse... Puma Biotechnology (PBYI) initiated with an Outperform at Credit Suisse... Rockwell Automation (ROK) initiated with a Neutral at Citi... Seattle Genetics (SGEN) initiated with an Outperform at Credit Suisse... Shopify (SHOP) initiated with an Outperform at Wedbush... Square (SQ) initiated with a Market Perform at William Blair... TESARO (TSRO) initiated with an Outperform at Wedbush... Tyco (TYC) initiated with a Neutral at Citi... Ultragenyx (RARE) initiated with an Outperform at Credit Suisse.
05/11/16
05/11/16
NO CHANGE

Leerink major pharma & biotech analyst holds analyst/industry conference call
Biotech Analyst Schmidt and Major Pharmaceuticals Analyst Fernandez, along with University of Chicago Departments of Pathology & Medicine, Professor Dr. Thomas F. Gajewski, discuss the tumor micro-environment on an Analyst/Industry conference call to be held on May 11 at 2 pm.
08/09/16
WELS
08/09/16
NO CHANGE
WELS
Five Prime weakness overdone, says Wells Fargo
After a trial of the OPDIVO cancer treatment of Five Prime's (FPRX) partner, Bristol Myers Squibb (BMY), showed disappointing results, Wells Fargo thinks that the nearly 9% decline in Five Prime's stock was overdone. The firm thinks that it's "premature" to determine that Merck's (MRK) Keytruda has overtaken OPDIVO. The firm believes that Five Prime's OPDIVO can redeem itself in upcoming studies, and it thinks that Five Prime's stock can advance if the actor-1 receptor is proven to be a worthwhile target ,whether or not OPDIVO is shown to be effective. The firm keeps an Outperform rating on Five Prime.
10/25/16
SBSH
10/25/16
INITIATION
Target $65
SBSH
Buy
Five Prime initiated with a Buy at Citi
Citi analyst Robyn Karnauskas started Five Prime Therapeutics with a Buy rating and $65 price target. The company has "multiple shots" on goal in various cancers, Karnauskas tells investors in a research note. She believes investors will assign higher value to the Cabiralizumab program once combo data with Opdivo is seen in 2017. The analyst sees fair value for Five Prime shares in the $65-$80 range.

TODAY'S FREE FLY STORIES

UPS

UPS

$107.62

0.26 (0.24%)

08:49
04/27/17
04/27
08:49
04/27/17
08:49
Hot Stocks
Breaking Hot Stocks news story on UPS »

UPS says seeing faster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 16

    May

  • 17

    May

  • 18

    May

  • 19

    May

  • 31

    May

MGM

MGM Resorts

$29.79

0.44 (1.50%)

08:48
04/27/17
04/27
08:48
04/27/17
08:48
Hot Stocks
MGM Resorts sees Q2 domestic gaming revenues lower, non-gaming to be up »

Jim Murren, Chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

MGP

MGM Growth

$28.20

0.22 (0.79%)

08:48
04/27/17
04/27
08:48
04/27/17
08:48
Earnings
Correction: MGM Growth reports Q1 EPS 20c, consensus 22c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

NOW

ServiceNow

$90.92

0.68 (0.75%)

08:47
04/27/17
04/27
08:47
04/27/17
08:47
Recommendations
ServiceNow analyst commentary  »

ServiceNow reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

MGM

MGM Resorts

$29.79

0.44 (1.50%)

08:47
04/27/17
04/27
08:47
04/27/17
08:47
Hot Stocks
MGM Resorts CFO says focused on maximizing cash flows, improving structure »

"Our commitment to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

DRYS

DryShips

$1.23

-0.1 (-7.52%)

08:46
04/27/17
04/27
08:46
04/27/17
08:46
Hot Stocks
DryShips announces full repayment of last legacy commercial lender »

DryShips announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

CWT

California Water Service

$38.30

0.65 (1.73%)

08:46
04/27/17
04/27
08:46
04/27/17
08:46
Earnings
California Water Service reports Q1 EPS 2c, consensus 9c »

Reports Q1 revenue $122M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

OAK

Oaktree Capital

08:46
04/27/17
04/27
08:46
04/27/17
08:46
Earnings
Oaktree Capital reports Q1 adj. EPS 86c, consensus 77c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

UAA

Under Armour

$19.71

0.18 (0.92%)

, CTL

CenturyLink

$25.87

-0.06 (-0.23%)

08:46
04/27/17
04/27
08:46
04/27/17
08:46
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

UAA

Under Armour

$19.71

0.18 (0.92%)

CTL

CenturyLink

$25.87

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 31

    May

CNMD

CONMED

$48.13

0.93 (1.97%)

08:45
04/27/17
04/27
08:45
04/27/17
08:45
Recommendations
CONMED analyst commentary  »

CONMED price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 24

    May

ALKS

Alkermes

$57.13

0.13 (0.23%)

08:45
04/27/17
04/27
08:45
04/27/17
08:45
Hot Stocks
Alkermes says NDA for ALKS 5461 on track for this year »

Alkermes says it is on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

  • 08

    Jun

MGM

MGM Resorts

$29.79

0.44 (1.50%)

08:45
04/27/17
04/27
08:45
04/27/17
08:45
Hot Stocks
MGM Resorts reports MGM China revenues up 7% to $502M »

Key first quarter results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

08:45
04/27/17
04/27
08:45
04/27/17
08:45
General news
FX Action: The dollar »

FX Action: The dollar…

AAL

American Airlines

$46.40

-0.21 (-0.45%)

08:44
04/27/17
04/27
08:44
04/27/17
08:44
Technical Analysis
American Airlines trades down after earnings, downgrade »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

WSM

Williams-Sonoma

$54.66

0.03 (0.05%)

08:43
04/27/17
04/27
08:43
04/27/17
08:43
Hot Stocks
Williams-Sonoma launches food collaboration with Trisha Yearwood »

Williams Sonoma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

FFIV

F5 Networks

$137.30

-0.89 (-0.64%)

08:43
04/27/17
04/27
08:43
04/27/17
08:43
Recommendations
F5 Networks analyst commentary  »

F5 Networks should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPWR

Monolithic Power

$93.71

-2.5 (-2.60%)

08:42
04/27/17
04/27
08:42
04/27/17
08:42
Recommendations
Monolithic Power analyst commentary  »

Monolithic Power price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$1.87

-0.1399 (-6.96%)

08:42
04/27/17
04/27
08:42
04/27/17
08:42
Hot Stocks
Cellectar says radiotherapeutic PDCS demonstrates increased survival benefit »

Cellectar Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$29.79

0.44 (1.50%)

08:42
04/27/17
04/27
08:42
04/27/17
08:42
Earnings
MGM Resorts reports Q1 EPS 36c, consensus 29c »

Reports Q1 revenue less…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

DLX

Deluxe

$71.85

0.26 (0.36%)

08:42
04/27/17
04/27
08:42
04/27/17
08:42
Earnings
Deluxe narrows FY17 EPS view to $5.15-$5.30 from $5.10-$5.30, consensus $5.21 »

Narrows FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

ALKS

Alkermes

$57.13

0.13 (0.23%)

08:42
04/27/17
04/27
08:42
04/27/17
08:42
Hot Stocks
Alkermes sees FDA meeting on ALKS 5461 in late June, early July »

Alkermes said on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

  • 08

    Jun

UPS

UPS

$107.62

0.26 (0.24%)

08:42
04/27/17
04/27
08:42
04/27/17
08:42
Hot Stocks
UPS says plans to announce additional strategic moves in coming weeks »

Comments from Q1 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 16

    May

  • 17

    May

  • 18

    May

  • 19

    May

  • 31

    May

RMTI

Rockwell Medical

$8.64

0.28 (3.35%)

08:41
04/27/17
04/27
08:41
04/27/17
08:41
Hot Stocks
Rockwell Medical to present on Triferic at Congress of IBIS »

Rockwell Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDSO

Medidata

$67.14

3.8 (6.00%)

08:41
04/27/17
04/27
08:41
04/27/17
08:41
Recommendations
Medidata analyst commentary  »

Medidata price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

TEUM

Pareteum

$0.71

0.0084 (1.20%)

08:40
04/27/17
04/27
08:40
04/27/17
08:40
Hot Stocks
Pareteum's cloud platform selected by THYNGS »

Pareteum's Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.